Patent ID: 9506909
Filing Date: 2016-11-29
CPC Classification: A23L,A61K,G01N

Claim Text:
1. A method for treating a patient having an increased risk of mortality caused by stroke, sudden cardiac death, myocardial infarction, heart failure, or intervention to treat coronary artery disease, the method comprising: measuring the amount of homoarginine in a blood sample from the patient; comparing the amount of homoarginine measured from the patient with a reference amount of homoarginine; determining the patient has an increased risk of mortality when the amount of hormoarginine from the patient is lower than the reference amount, wherein the increased risk of mortality is increased risk of mortality caused by stroke, sudden cardiac death, myocardial infarction, heart failure, or intervention to treat coronary artery disease; and treating the patient determined to be at increased risk of mortality by administering homoarginine to said patient.